VK13 (Compound 6) is a potent inhibitor of human cathepsin L (hCatL) and SARS-CoV-2 3CLpro (3CL-PR), with Ki values of 2.6 nM and 0.55 nM, respectively. It also exhibits activity against CoV-2, with an EC50 value of 1.25 µM.
Molecular Weight:
452.503
Formula:
C24H28N4O5
Target:
Cysteine Protease|||SARS-CoV
T205197
* VAT and and shipping costs not included. Errors and price changes excepted